Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients".

Verma, Ravneet Ravinder; Gupta, Nitin; Singh, Mugdha

Verma, Ravneet Ravinder; Gupta, Nitin; Singh, Mugdha.

Verma RR; Department of Otorhinolaryngology, Head and Neck Surgery, Government Medical College and Hospital, Sector 32, Chandigarh, India. Electronic address: ravneetrverma@gmail.com.
Gupta N; Department of Otorhinolaryngology, Head and Neck Surgery, Government Medical College and Hospital, Sector 32, Chandigarh, India.
Singh M; Department of Otorhinolaryngology, Head and Neck Surgery, Government Medical College and Hospital, Sector 32, Chandigarh, India.

Am J Otolaryngol ; 42(5): 103103, 2021.

Article in English | MEDLINE | ID: covidwho-1252415

Subject(s)

COVID-19; Nasal Sprays; Anosmia; Dysgeusia; Fluticasone; Humans; SARS-CoV-2; Triamcinolone

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nasal Sprays / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Am J Otolaryngol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google